MedTrace Logo

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

NCT03710902 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 405

Last updated 2025-03-20

No results posted yet for this study

Summary

The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.

Conditions

Interventions

DIAGNOSTIC_TEST

ECG monitoring for 3 weeks

A 3-week continuous ECG monitoring to detect occult AF.

OTHER

Self-monitoring of BP and self-titration of antihypertensive medication

One-week monthly self-monitoring of BP and self-titration of antihypertensive medication according to a pre-specified protocol, assisted with a mobile device application.

Sponsors & Collaborators

  • Jukka Putaala

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-17
Primary Completion
2026-09-30
Completion
2028-09-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03710902 on ClinicalTrials.gov